Press Releases
-
Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections
Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Sep 5, 2022
-
CapnoPharm awarded as drug delivery platform Capnodrug® reaches finals of Reuters Pharma Europe Award 2022
CapnoPharm is proud to announce its selection as Finalist of the prestigious Reuters Pharma Europe Award 2022 for its Cancer drug delivery innovation - Capnodrug® - in the Health Entrepreneur Award category.
Sep 5, 2022
-
Sakura Finetek offers the optimal advanced stained slide with the new Tissue-Tek Genie®
Sakura Finetek Europe has announced the launch of its newest solution Tissue-Tek Genie, an Advanced staining system.
Sep 4, 2022
-
Medix Biochemica Appoints Dr. Michele Pedrocchi, Former Head of Business Development for Roche Diagnostics, to its Board of Directors
Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.
Sep 4, 2022
-
Hydrophilic Polymers Exhibit Boundless Opportunities for Multiple Fields
-
Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals
-
Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Needs
-
Creative Biogene Updates Gene Knockout Services for C-elegans Using Mos 1-Mediated Deletion Method
-
BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity
-
PseudoUridine Phosphoramidites for Efficient and Reliable Syntheses of RNA Oligonucleotides
-
Clinical trials legal service provider cements expansion plans with first US office
Clinical trials legal service provider cements expansion plans with first US office CTA Focus’ North Carolina base will provide seamless access to world-class services
Aug 31, 2022
-
Curebase Names Digital Infrastructure Veteran Matt Lanier as VP of Engineering
Curebase, a company committed to democratizing access to clinical studies, has named veteran digital infrastructure executive Matt Lanier as vice president of engineering.
Aug 29, 2022
-
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor
Aug 29, 2022
-
Rho Announces Findings from Study it Coordinated to Explore Therapy for Reducing Asthma Attacks Among Disadvantaged Urban Youth
Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.
Aug 10, 2022
-
Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Indica Labs and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) has announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
Aug 29, 2022
-
NDA Group announces the expansion of the NDA Advisory Board with the appointment of Jan Sjöberg MD, Ph.D
NDA Group are pleased to announce the expansion of the NDA Advisory Board with the appointment of Jan Sjöberg MD, Ph.D., specialist in internal medicine and haematology and associate professor at Karolinska Institutet.
Aug 29, 2022
-
Thermo Fisher Scientific Showcases Latest Innovations to Improve Biopharmaceutical and Proteomics Workflows
Thermo Fisher Scientific Inc. is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges.
Aug 29, 2022
-
Biopharma PEG Provides PEG Derivatives Used As PROTAC Linker
-
Huateng Pharma Supplies SGLT-2 inhibitors Against Type 2 Diabetes
-
ChargePoint Technology Acquires PuroVaso